Cargando…
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA(2)DS(2)‐VASc Score of 1 (Men) or 2 (Women)?
BACKGROUND: Recent studies demonstrated that oral anticoagulants (OACs) should be considered for patients with atrial fibrillation and 1 risk factor in addition to sex. Because age is an important determinant of ischemic stroke, the strategy for stroke prevention may be different for these patients...
Autores principales: | Hung, Yuan, Chao, Tze‐Fan, Liu, Chia‐Jen, Tuan, Ta‐Chuan, Lin, Yenn‐Jiang, Chang, Shih‐Lin, Lo, Li‐Wei, Hu, Yu‐Feng, Liao, Jo‐Nan, Chung, Fa‐Po, Lin, Wen‐Yu, Lin, Wei‐Shiang, Cheng, Shu‐Meng, Chen, Tzeng‐Ji, Lip, Gregory Y. H., Chen, Shih‐Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121486/ https://www.ncbi.nlm.nih.gov/pubmed/27702803 http://dx.doi.org/10.1161/JAHA.116.003839 |
Ejemplares similares
-
Applying the CHA(2)DS(2)-VASc score to predict the risk of future acute coronary syndrome in patients receiving catheter ablation for atrial fibrillation
por: Chou, Ching-Yao, et al.
Publicado: (2020) -
CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022) -
CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018) -
Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014) -
CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)